CCL2 and systemic lupus erythematosus: Mice receiving three transfusions compared to those without any or one transfusion saw better outcomes and regression of SLE symptoms, exemplified by decreased urine protein levels, reduced monocyte chemotactic protein-1 (MCP-1) levels, and improved renal formation.